Project Grant R01HL178953
Award Date 7/15/26
Completion Date 3/31/30
Dollars Obligated $815K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
- Federal Grant Award Summary Duke University's Office of Research Administration received a $160,040 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 30, 2025, with completion targeted for September 4, 2027. The award funds research investigating the application of Partially Ordered Polypeptides (POPs)—a novel injectable biomaterial scaffold—to improve patient outcomes following...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $959,043 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 5, 2025, with completion targeted for May 31, 2029. The award funds research into mechanistic diversity in biased angiotensin receptor ligands, specifically examining how different ligand classes activate the angiotensin II...
- Federal Project Grant Summary The University of Pennsylvania received a $1.14 million Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective March 20, 2026, with an ultimate completion date of January 31, 2033. This award supports the principal investigator's translational research program applying gene-editing therapeutics to cardiovascular and related systemic diseases. The research builds...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $242,250 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for August 31, 2027. This feasibility study (R03 mechanism) implements arteriovenous blood sampling techniques to measure regional metabolic changes in the heart and legs during submaximal exercise...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $735,071 Project Grant to Indiana University Indianapolis on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports research and development of next-generation dystrophin gene therapy for Duchenne Muscular Dystrophy (DMD), with completion targeted for March 31, 2030. The project deliverables include development of an improved triple vector system...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $165,456 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with completion scheduled for June 30, 2030. This award supports fundamental research investigating the role of protein S-palmitoylation in transforming growth factor beta (TGF-β) signaling and its contribution to...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Sanford Burnham Prebys Medical Discovery Institute a $1.6M Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective July 1, 2026, through March 31, 2028, to develop a single-construct gene therapy for enhanced cardiac repair. The project addresses cardiac fibrosis—a pathological feature common to multiple cardiovascular disease states that currently lacks effective antifibrotic treatment...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $242,250 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 18, 2026, with completion targeted for May 31, 2028. This secondary analysis project addresses physical inactivity, which contributes to 5.4 million excess deaths annually, by investigating genetic predictors of exercise and physical...
- Federal Project Grant Award Summary Case Western Reserve University's Office of Research Administration received a $1.53 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 1, 2026, with completion targeted for May 31, 2028. The award funds research and development of a novel "bait-and-switch" gene therapy delivery platform designed to overcome critical barriers in...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $1,532,545 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 5, 2026, with completion targeted for February 29, 2028. The project examines the effects of income-based health insurance benefit designs on cardiovascular disease (CVD) outcomes and health disparities among working-age adults. Specifically, the...